|
1
|
Wang Z, Yin J, Bai M, Yang J, Jiang C, Yi X, Liu Y, Gao C. New Polyene Macrolide Compounds from Mangrove-Derived Strain Streptomyces hiroshimensis GXIMD 06359: Isolation, Antifungal Activity, and Mechanism against Talaromyces marneffei. Mar Drugs 2024; 22:38. [PMID: 38248663 PMCID: PMC10819995 DOI: 10.3390/md22010038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Revised: 01/05/2024] [Accepted: 01/06/2024] [Indexed: 01/23/2024] Open
Abstract
Mangrove-derived actinomycetes represent a rich source of novel bioactive natural products in drug discovery. In this study, four new polyene macrolide antibiotics antifungalmycin B-E (1-4), along with seven known analogs (5-11), were isolated from the fermentation broth of the mangrove strain Streptomyces hiroshimensis GXIMD 06359. All compounds from this strain were purified using semi-preparative HPLC and Sephadex LH-20 gel filtration while following an antifungal activity-guided fractionation. Their structures were elucidated through spectroscopic techniques including UV, HR-ESI-MS, and NMR. These compounds exhibited broad-spectrum antifungal activity against Talaromyces marneffei with minimum inhibitory concentration (MIC) values being in the range of 2-128 μg/mL except compound 2. This is the first report of polyene derivatives produced by S. hiroshimensis as bioactive compounds against T. marneffei. In vitro studies showed that compound 1 exerted a significantly stronger antifungal activity against T. marneffei than other new compounds, and the antifungal mechanism of compound 1 may be related to the disrupted cell membrane, which causes mitochondrial dysfunction, resulting in leakage of intracellular biological components, and subsequently, cell death. Taken together, this study provides a basis for compound 1 preventing and controlling talaromycosis.
Collapse
Affiliation(s)
- Zhou Wang
- Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China; (Z.W.); (J.Y.); (M.B.); (J.Y.); (C.J.)
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China;
| | - Jianglin Yin
- Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China; (Z.W.); (J.Y.); (M.B.); (J.Y.); (C.J.)
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China;
- Guangxi Scientific Research Center of Traditional Chinese Medicine, Nanning 530200, China
| | - Meng Bai
- Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China; (Z.W.); (J.Y.); (M.B.); (J.Y.); (C.J.)
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China;
| | - Jie Yang
- Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China; (Z.W.); (J.Y.); (M.B.); (J.Y.); (C.J.)
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China;
| | - Cuiping Jiang
- Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China; (Z.W.); (J.Y.); (M.B.); (J.Y.); (C.J.)
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China;
| | - Xiangxi Yi
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China;
| | - Yonghong Liu
- Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China; (Z.W.); (J.Y.); (M.B.); (J.Y.); (C.J.)
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China;
| | - Chenghai Gao
- Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China; (Z.W.); (J.Y.); (M.B.); (J.Y.); (C.J.)
- Guangxi Key Laboratory of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China;
| |
Collapse
|